Health
Moderna Gets $590 Million from US to Study Bird Flu Vaccine
- Biotech company set to advance vaccine into late-stage study
- US health officials stepping up efforts amid ongoing outbreak
This article is for subscribers only.
Moderna Inc. was awarded an additional $590 million from the US government to help the company develop a vaccine aimed at protecting people from bird flu.
The funding will support late-stage development and licensing of pre-pandemic vaccines and expansion of human studies for up to five additional subtypes of pandemic influenza, according to a statement Friday.